← Research library

Use of Bemitil in patients with progressive muscular dystrophies

Comparison in people · 1992

What was studied
22 patients with progressive myodystrophy
Main finding
Reports changes in lipid peroxidation and discusses glucose metabolism in patients receiving Bemitil.

Reported findings and study design

22 patients with progressive muscular dystrophy treated with Bemitil.

Population or model 22 patients with progressive myodystrophy

Results · Previously retrieved indexed abstract; numerical statements checked against the saved source text
MeasureResultComparison, timing and statistics
Lipid peroxidation and metabolic exchangeFavorable changes reportedNo numerical treatment effect or regimen given

Values describe this study and its comparison. Unreported effect sizes and missing denominators have not been inferred.

Source for these results ↗ · Reviewed 2026-10-29

Study limitations and source details

Study limitations

  • The abstract does not establish a randomized comparison or durable disease-modifying benefit.
  • The 1991 and 1992 publications may share patients; they are not assumed to be independent replications.

Source details

Indexed citation and abstract checked; full methods and risk of bias remain unreviewed.

Sources checked

Citation

Human comparative studyEnglish abstract

V. S. Lobzin, L. A. Saikova, M. L. Chukhlovina, V. G. Pustozerov. Use of Bemitil in patients with progressive muscular dystrophies Lik Sprava. (4):85–87. PMID 1441389

Study source ↗ · Bibliography entry · Link to this summary

Related compounds

Editorial policy and evidence standards